These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15708355

  • 21. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
    Sharma I, Dhawan V, Mahajan N, Saha SC, Dhaliwal LK.
    Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
    [Abstract] [Full Text] [Related]

  • 22. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
    Li J, Li JJ, He JG, Nan JL, Guo YL, Xiong CM.
    Cardiovasc Ther; 2010 Oct; 28(1):8-14. PubMed ID: 20074254
    [Abstract] [Full Text] [Related]

  • 23. Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway.
    Yuan X, Deng Y, Guo X, Shang J, Zhu D, Liu H.
    Biochem Biophys Res Commun; 2014 Mar 28; 446(1):292-7. PubMed ID: 24582748
    [Abstract] [Full Text] [Related]

  • 24. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
    Shyu KG, Wang BW, Chen WJ, Kuan P, Hung CR.
    Eur J Heart Fail; 2010 Mar 28; 12(3):219-26. PubMed ID: 20156938
    [Abstract] [Full Text] [Related]

  • 25. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression.
    Wang L, Zhang X, Liu L, Yang R, Cui L, Li M.
    Neurosci Lett; 2010 Mar 08; 471(3):152-6. PubMed ID: 20100543
    [Abstract] [Full Text] [Related]

  • 26. In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin.
    Mahajan N, Dhawan V.
    Arch Med Res; 2010 Apr 08; 41(3):154-61. PubMed ID: 20682172
    [Abstract] [Full Text] [Related]

  • 27. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A, Iglesias R, Giralt M, Villarroya F.
    Cardiovasc Res; 2011 May 01; 90(2):276-84. PubMed ID: 21115502
    [Abstract] [Full Text] [Related]

  • 28. Regulation of phospholamban and sarcoplasmic reticulum Ca2+-ATPase by atorvastatin: implication for cardiac hypertrophy.
    Kang L, Fang Q, Hu SJ.
    Arch Pharm Res; 2007 May 01; 30(5):596-602. PubMed ID: 17615679
    [Abstract] [Full Text] [Related]

  • 29. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
    Chiu CZ, Wang BW, Shyu KG.
    Eur J Clin Invest; 2012 May 01; 42(5):564-71. PubMed ID: 22129233
    [Abstract] [Full Text] [Related]

  • 30. [Effect of atorvastatin on ACE2 expression in pressure overload induced cardiac hypertrophy in rats].
    Qin XT, Jia CW, Pan M, Shen AG, Jing HM.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May 01; 33(5):438-42. PubMed ID: 18544849
    [Abstract] [Full Text] [Related]

  • 31. Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction.
    Seymour EM, Bennink MR, Watts SW, Bolling SF.
    Hypertension; 2010 May 01; 55(5):1179-85. PubMed ID: 20231522
    [Abstract] [Full Text] [Related]

  • 32. Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
    Sheng L, Yang X, Ye P, Liu YX, Han CG.
    Chin Med Sci J; 2015 Dec 01; 30(4):245-51. PubMed ID: 26960306
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK, Kwon KB, Koo BS, Han MJ, Song MY, Song EK, Han MK, Park JW, Ryu DG, Park BH.
    Int J Biochem Cell Biol; 2007 Dec 01; 39(6):1260-75. PubMed ID: 17521952
    [Abstract] [Full Text] [Related]

  • 35. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Senthil V, Chen SN, Tsybouleva N, Halder T, Nagueh SF, Willerson JT, Roberts R, Marian AJ.
    Circ Res; 2005 Aug 05; 97(3):285-92. PubMed ID: 16020756
    [Abstract] [Full Text] [Related]

  • 36. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ, Yao L, Chen TG, Yu M, Wang LH, Chen JZ.
    Chin Med J (Engl); 2007 Nov 05; 120(21):1902-7. PubMed ID: 18067764
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages.
    Qiu G, Hill JS.
    J Lipid Res; 2007 Oct 05; 48(10):2112-22. PubMed ID: 17644777
    [Abstract] [Full Text] [Related]

  • 39. Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats.
    Zhang Y, Dai L, Wu S, Chen P, Zhao S.
    Chin Med J (Engl); 2014 Oct 05; 127(5):869-72. PubMed ID: 24571879
    [Abstract] [Full Text] [Related]

  • 40. [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].
    HUANG XS, ZHAO SP, BAI L, ZHANG Q, HU M, ZHAO W.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep 05; 38(9):809-13. PubMed ID: 21092650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.